Anticancer activity of the Aurora A kinase inhibitor MK-5108 in non-small-cell lung cancer (NSCLC) in vitro as monotherapy and in combination with chemotherapies
Crossref DOI link: https://doi.org/10.1007/s00432-014-1675-6
Published Online: 2014-04-23
Published Print: 2014-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Chinn, Danielle C.
Holland, William S.
Mack, Philip C.
Text and Data Mining valid from 2014-04-23